Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Since the discovery of the immunomodulation property of mesenchymal stem cells (MSCs) about a decade ago, it has been extensively investigated whether MSCs can be used for the treatment of immune-related diseases, such as graftversus- host disease (GvHD). However, how to evaluate the efficacy of human MSCs for the clinical trial is still unclear. We used an MHC-mismatched model of GvHD (B6 into BALB/c). Surprisingly, the administration of the human MSCs (hMSCs) could reduce the GvHD-related mortality of the mouse recipients and xenogeneically inhibit mouse T-cell proliferation and IFN-γ production in vitro. We recently established a new protocol for the isolation of a homogeneous population of MSCs called subfractionation culturing methods (SCM), and established a library of clonal MSC lines. Therefore, we also investigated whether MSCs isolated by the conventional gradient centrifugation method (GCM) and SCM show different efficacy in vivo. Intriguingly, clonal hMSCs (hcMSCs) isolated by SCM showed better efficacy than hMSCs isolated by GCM. Based on these results, the MHC-mismatched model of GvHD may be useful for evaluating the efficacy of human MSCs before the clinical trial. The results of this study suggest that different MSC lines may show different efficacy in vivo and in vitro.
Abstract
Since the discovery of the immunomodulation property of mesenchymal stem cells (MSCs) about a decade ago, it has been extensively investigated whether MSCs can be used for the treatment of immune-related diseases, such as graftversus- host disease (GvHD). However, how to evaluate the efficacy of human MSCs for the clinical trial is still unclear. We used an MHC-mismatched model of GvHD (B6 into BALB/c). Surprisingly, the administration of the human MSCs (hMSCs) could reduce the GvHD-related mortality of the mouse recipients and xenogeneically inhibit mouse T-cell proliferation and IFN-γ production in vitro. We recently established a new protocol for the isolation of a homogeneous population of MSCs called subfractionation culturing methods (SCM), and established a library of clonal MSC lines. Therefore, we also investigated whether MSCs isolated by the conventional gradient centrifugation method (GCM) and SCM show different efficacy in vivo. Intriguingly, clonal hMSCs (hcMSCs) isolated by SCM showed better efficacy than hMSCs isolated by GCM. Based on these results, the MHC-mismatched model of GvHD may be useful for evaluating the efficacy of human MSCs before the clinical trial. The results of this study suggest that different MSC lines may show different efficacy in vivo and in vitro.
참고문헌 (35)
- Goker, H., "Acute graft-vs-host disease: pathobiology and management", Exp. Hematol, 29, pp.259~277 (2001)
- Menillo, S. A., "Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation", Bone Marrow. Transplant, 28, pp.807~808 (2001)
- Deeg, H. J, "How I treat refractory acute GVHD", Blood, 109, pp.4119~4126 (2007)
- Rager, A., "Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD", Bone Marrow. Transplant, 46, pp.430~435 (2011)
- Schub, N., "Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective", Bone Marrow. Transplant, 46, pp.143~147 (2011)
- Prockop, D. J, "Marrow stromal cells as stem cells for nonhematopoietic tissues", Science, 276, pp.71~74 (1997)
- Branch, M. J., "Mesenchymal stem cells in the human corneal limbal stroma", Invest. Ophthalmol. Vis. Sci, 53, pp.5109~5116 (2012)
- Tse, W. T., "Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation", Transplantation, 75, pp.389~397 (2003)
- Di Nicola, M., "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli", Blood, 99, pp.3838~3843 (2002)
- Jiang, X. X., "Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells", Blood, 105, pp.4120~4126 (2005)
- Sotiropoulou, P. A., "Interactions between human mesenchymal stem cells and natural killer cells", Stem. Cells, 24, pp.74~85 (2006)
- Corcione, A., "Human mesenchymal stem cells modulate B-cell functions", Blood, 107, pp.367~372 (2006)
- Glennie, S., "Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells", Blood, 105, pp.2821~2827 (2005)
- Le Blanc, K., "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells", Lancet, 363, pp.1439~1441 (2004)
- Le Blanc, K., "Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study", Lancet, 371, pp.1579~1586 (2008)
- Ringden, O., "Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease", Transplantation, 81, pp.1390~1397 (2006)
- Allison, M., "Genzyme backs osiris, despite prochymal flop", Nat. Biotechnol, 27, pp.966~967 (2009)
- Li, W. J., "Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study", J. Tissue. Eng. Regen. Med, 3, pp.1~10 (2009)
- Liao, W., "Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke", Transplantation, 87, pp.350~359 (2009)
- Yan, H., "Repair of full-thickness cartilage defects with cells of different origin in a rabbit model", Arthroscopy, 23, pp.178~187 (2007)
- Bruck, F., "Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease", Cytotherapy, 15, pp.267~279 (2013)
- Song, S. U., "Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion", Stem. Cells. Dev, 17, pp.451~461 (2008)
- Jeon, M. S., "Characterization of mouse clonal mesenchymal stem cell lines established by subfractionation culturing method", World. J. Stem. Cells, 3, pp.70~82 (2011)
- Saito, T., "Xenotransplant cardiac chimera: immune tolerance of adult stem cells", Ann. Thorac. Surg, 74, pp.19~24 (2002)
- Liechty, K. W., "Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep", Nat. Med, 6, pp.1282~1286 (2000)
- Jeon, M. S., "Xenoreactivity of human clonal mesenchymal stem cells in a major histocompatibility complex-matched allogeneic graft-versus-host disease mouse model", Cell. Immunol, 261, pp.57~63 (2010)
- Ren, G., "Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide", Cell. Stem. Cell, 2, pp.141~150 (2008)
- Dazzi, F., "Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells", Eur. J. Immunol, 38, pp.1479~1482 (2008)
- Sato, K., "Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells", Blood, 109, pp.228~234 (2007)
- Katz, J. B., "Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape", Immunol. Rev, 222, pp.206~221 (2008)
- Baron, F., "Mesenchymal stromal cells: a new tool against graft-versus-host disease?", Biol. Blood Marrow. Transplant, 18, pp.822~840 (2012)
- Sudres, M., "Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice", J. Immunol, 176, pp.7761~7767 (2006)
- Polchert, D., "IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease", Eur. J. Immunol, 38, pp.1745~1755 (2008)
- Yanez, R., "Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease", Stem. Cells, 24, pp.2582~2591 (2006)
- Jang, M. J., "Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice", Acta. Haematol, 129, pp.197~206 (2013)